StockData
C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc. (CCCC) stock

CCCCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/303% above fair value
$2.53−0.12 (-4.53%)

Close on Nov 17, 2026Market cap $311.25MP/E –Yield –

C4 Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

C4 Therapeutics's market cap was $355.20M on Nov 11, 2026, against $201.01M a year earlier. Over the last 5 years it ranged from $73.11M to $1.56B, with a median of $317.76M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$355.20M+150.7%
2025Dec 31, 2025$141.67M-44.2%
2024Dec 31, 2024$254.03M-8.7%
2023Dec 29, 2023$278.32M-3.6%
2022Dec 30, 2022$288.81M-81.5%
2021Dec 31, 2021$1.56B+2790.2%
2020Dec 31, 2020$54.14M–

More C4 Therapeutics figures

See a number that looks wrong?